Overview

-Distributes a wide range of brand-name, specialty brand-name, and generic pharmaceuticals, over-the-counter (OTC) healthcare products, outsourced compounded sterile preparations, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, mail-order pharmacies, medical clinics, independent and chain retail pharmacies, long-term care, and alternate site pharmacies and other customers. -Provides pharmaceutical distribution (including plasma and other blood products, vaccines, injectible pharmaceuticals, and other specialty pharmaceutical products) and also other services to physicians specialized in a variety of disease states, especially cancer, and to other healthcare providers, including dialysis clinics and hospitals. -It also offers data analytics, outcomes research, and additional services to pharmaceutical and biotechnology manufacturers; pharmacy management; staffing and additional consulting services; supply management software to retail and institutional healthcare providers; and provides packaging solutions to institutional and retail healthcare providers. -MWI Animal Health (MWI): -Sells pharmaceuticals, parasiticides, vaccines, micro feed ingredients, diagnostics, and other products to customers in both the production animal and companion animal markets. In FY2023, the segment incurred a capital expenditure of US$268.069 million which declined 9.3% YoY.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.